How DePasquale was paid
$346,824 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Other | Total |
|---|---|---|---|---|
| Michael W. DePasqualeChief Executive Officer | $312,875 | $33,750 | $199 | $346,824 |
| Cecilia C. WelchChief Financial Officer | $225,312 | $26,250 | $518 | $252,080 |
| James D. SullivanChief Legal Officer | $252,135 | $30,000 | $162,186 | $444,321 |
What changed and why
- $347K2025 CEO total compensation was $346,824, up from $309,491 in 2024.
- 2025 executive base compensation increased after levels had not been increased since 2022.
- Restricted stock awards were issued to each named executive officer in 2025.
- Performance-based bonuses have historically depended on revenue milestones established by the compensation committee.
- $161KJames Sullivan received $161,389 in sales commissions within all other compensation.
- The company does not use a prescribed formula or target weighting for salary, bonuses and equity awards.
Other Bio Key International proxy statements
- 2025 proxy statement
Michael W. DePasquale paid $309,491 (+6% on the year).
Filed Jun 27, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.